Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001493152-26-009587

Options or other derivatives

  • CEO & President acquired 50,025 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Equels Thomas K CEO & President 2026-03-06 Other acquisition · Series G Convertible Preferred Stock +25 $25,000.00 $625,000 25 D
Equels Thomas K CEO & President 2026-03-06 Other acquisition · Class G Warrants +50,000 50,000 D
Loading xslF345X05/ownership.xml…